Eliglustat

Details

Files

Generic Name:

Eliglustat

Project Status:

Complete

Therapeutic Area:

Gaucher disease

Manufacturer:

Sanofi Genzyme

Call for patient/clinician input open:

December 15, 2016

Brand Name:

Cerdelga

Project Line:

Reimbursement Review

Project Number:

SR0511-000

Call for patient/clinician input closed:

February 10, 2017

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Gaucher disease

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

July 26, 2017

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : December 15, 2016